Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia

Clinical Journal of Pain

Volumn 27, Issue 4, 2011, Pages 285-288

  Vlainich, Roberto ^a   Issy, Adriana MacHado ^a   Sakata, Rioko Kimiko ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fibromyalgia; intravenous lidocaine; neurotransmitters; pain

Indexed keywords

AMITRIPTYLINE; DOPAMINE; LIDOCAINE; NORADRENALIN; SEROTONIN;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; FEMALE; FIBROMYALGIA; HUMAN; MONOTHERAPY; NORADRENALIN BLOOD LEVEL; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN BLOOD LEVEL;

EID: 79954807088     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181ffbfde     Document Type: Article

References (47)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160-172. (Pubitemid 20098653)
2. Buskila D. Neuroendocrine mechanisms in fibromyalgia\chronic fatigue. Best Pract Res Clin Rheum. 2001;15:747-758.
3. Cohen ML, Quinter JL. Fibromyalgia syndrome: a problem of tautology. Lancet. 1993;342:906-908.
4. Finnerup NB, Sorensen FB, Johannesen IL, et al. Intravenous lidocaine relieves spinal cord injury pain. Anesthesiology. 2005; 102:1023-1030.
5. Rowbothan MC, Reisner-Keller LA, Fields HL. Both intra-venous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 1991;41:1024-1028.
6. Lesley M, Arnold MD. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med. 2007;8:S63-S74.
7. Berger AE, Dukes E, Martin S, et al. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498-1508. (Pubitemid 47228612)
8. Rosborg I, Hvllen E, Lidbeck J, et al. Trace element pattern in patients with fibromyalgia. Sci Total Environ. 2007;385:20-27. (Pubitemid 47368609)
9. Dadabhoy D, Clauw DJ. Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep. 2005;9:399-404. (Pubitemid 41782679)
10. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50:944-952. (Pubitemid 38326195)
11. Williams DA, Mease PJ, McLean SA, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005; 32:1975-1985. (Pubitemid 41429029)
12. Lawson K. Tricyclic antidepressants and fibromyalgia: what is the mechanism of action? Expert Opin Invest Drugs. 2002;11: 1437-1445. (Pubitemid 35174939)
13. Littlejohn GO, Guymer EK. Fibromyalgia syndrome: which antidepressant drug should we choose. Curr Pharm Des. 2006;12:3-9.
14. Kalso E. Pharmacological Management of Pain: Anticonvul-sants, Antidepressants and Adjuvants Analgesics. Pain\An Updated Review: Refresher Course Syllabus. Seattle: IASP Press; 2005:19-29.
15. Inanici F, Yunus MB. Management of fibromyalgia syndrome. In: Rachlin ES, Rachlin IS. Myofascial Pain and Fibromyalgia. 2nd ed. St Louis: Mosby; 2002:33-58.
16. Sharvav Y, Singer E, Schmidt E, et al. The analgesic effect of amitriptyline on chronic facial pain. Pain. 1987;31:199-209.
17. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry. 1996;61:285-290. (Pubitemid 26293724)
18. Cesaro O, Ollat H. Pain and its treatments. Eur Neurol. 1997; 38:209-215. (Pubitemid 27429868)
19. Ziegler VE, Clayton PJ, Biggs JT. A comparison study of amitriptyline and nortriptyline with plasma levels. Arch Gen Psychiatry. 1997;34:607-612.
20. Rowbotham MC. Treatment of Neuropathic Pain: Perspective on Current Options. Pain\An Updated Review: Refresher Course Syllabus. Seattle: IASP Press; 2005;107-119.
21. Baron R, Binder A, Ludwig J, et al. Diagnostic tools and evidence-based treatment of complex regional pain syndrome. In: Justins DM, ed. Pain\An Update Review: Refresher Course Syllabus. Seattle: IASP; 2005:293-306.
22. Attal N, Rouaud J, Brasseur L, et al. Systemic lidocaine in pain due to nerve injury and predictors of response. Neurology. 2004;62:218-225. (Pubitemid 38167128)
23. Sorensen J, Bengtsson A, Ahlner J, et al. Fibromyalgia-are there different mechanisms in the processing of pain? A double-blind crossover comparison of analgesic drugs. J Rheumatol. 1997;24:1615-1621. (Pubitemid 27320707)
24. Bennett MI, Tai YM. Intravenous lignocaine in the manage-ment of primary fibromyalgia syndrome. Int J Clin Pharmacol Res. 1995;15:115-119.
25. Schafranski MD, Malucelli T, Machado F, et al. Intravenous lidocaine for fibromyalgia syndrome: an open trial. Clin Rheumatol. 2009;28:853-855. [Epub 2009].
26. Ness TJ. Intravenous lidocaine inhibits visceral nociceptive reflexes and spinal neurons in the rat. Anesthesiology. 2000;92: 1685-1691. (Pubitemid 30412489)
27. Koppert W, Ostermeier N, Sittl R, et al. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain. 2000;85:217-224. (Pubitemid 30110762)
28. Abram SE, Yaksh TL. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology. 1994;80:383-391. (Pubitemid 24064041)
29. Attal N, Gaude V, Brasseurn L, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysi-cal study. Neurology. 2000;54:564-574. (Pubitemid 30082919)
30. Wu CL, Tella P, Staats PS, et al. Analgesia effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, cross-over trial. Anesthesiology. 2002;96:841-848. (Pubitemid 34266676)
31. Treister R, Pud D, Ebstein RP, et al. Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans. Pain. 2009; 147:187-193.
32. Stratz T, Samborski W, Hrycaj P, et al. Serotonin concentra-tion in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis. Med Klin (Munich). 1993;88:458-462.
33. Dessein PH, Shipton EA, Joffe BI, et al. Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain. 1999;83:313-319. (Pubitemid 29479291)
34. Wolfe F, Russell IJ, Vipraio G, et al. Serotonin levels, pain threshold and fibromyalgia symptoms in the general popula-tion. J Rheumatol. 1997;24:555-559. (Pubitemid 27153424)
35. Jaschko G, Hepp U, Berkhoff M, et al. Serum serotonin levels are not useful in diagnosing fibromyalgia. Ann Rheum Dis. 2007;66:1267-1268. (Pubitemid 47315536)
36. Cordero MD, Alcocer-Gomez E, Cano-Garca FJ, et al. Low levels of serotonin in serum correlates with severity of fibromyalgia. Med Clin (Barc). 2010 Jun 28. [Epub ahead of print] Spanish.
37. Arvidsson U, Culheim S, Ulfhake B, et al. Quantitative and qualitative aspects on the distribution of 5-HT and its coexistence with substance P and TRH in cat ventral medullary neurons published erratum appears. J Chem Neuroanat. 1994;7:285-287.
38. Walker PD, Riley LA, Hart RP, et al. Serotonin regulation of tachykinin biosynthesis in the rat neostriatum. Brain Res. 1991;546:33-39.
39. Sharma HS, Nyberg F, Olson Y, et al. Alteration of substance P after trauma to the spinal cord: an experimental study in the rat. Neuroscience. 1990;38:205-212. (Pubitemid 20334934)
40. Moldofsky H. Rheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system serotonin and pain. Adv Neurol. 1982;33:51-57.
41. Arnold LM. New therapies in fibromyalgia. Arthritis Res Ther. 2008;8:212.
42. Clauw DJ. Perspectives on fatigue from the study of chronic fatigue syndrome and related conditions. PM R. 2010;2:414-430.
43. Yunus MB, Inanici F. Fibromyalgia syndrome: clinical features, diagnosis, and biopathophysiologic mechanisms. In: Rachlin ES, Rachlin IS. Myofascial Pain and Fibromyalgia. 2nd ed. St Louis: Mosby; 2002:3-31.
44. Staud R. Evidence of involvement of central neural mechan-isms in generating fibromyalgia pain. Curr Rheumatol Rep. 2002;4:299-305.
45. Altier N, Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 1999;65:2269-2287. (Pubitemid 29531031)
46. Da Silva Torres IL, Cucco SN, Bassani M, et al. Long-lasting delayed hyperalgesia after chronic restraint stress in rats\effect of morphine administration. Neurosci Res. 2003;45: 277-283. (Pubitemid 36298810)
47. Wood PB. Stress and dopamine: implications for the patho-physiology of chronic widespread pain. Med Hypotheses. 2004;62:420-424. (Pubitemid 38388907)